Latest / Research To Practice | Oncology Videos
ER-Positive Metastatic Breast Cancer — A Roundtable Discussion on the Current and Future Role of Oral SERDs
Featuring slide presentations and related discussion from Prof Francois-Clement Bidard, Dr Hope S Rugo, Dr Rebecca Shatsky and Dr Seth Wander, including the following topics:
Optimal approach to biomarker testing for patients with ER-positive metastatic breast cancer (mBC) (0:00)
Case: A woman in her early 70s with recurrent ER-positive, HER2-negative mBC receives elacestrant (15:15)
Case: A woman in her early 60s with ER-positive, HER2-low, PIK3CA-mutated mBC receives inavolisib-based therapy and experiences no disease progression for 24 months (18:02)
Role of oral selective estrogen…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.